Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol
Crossref DOI link: https://doi.org/10.1134/S1063774522070045
Published Online: 2023-02-10
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cai, Jie
Zhang, Ruirui
Text and Data Mining valid from 2022-12-01
Version of Record valid from 2022-12-01
Article History
Received: 4 November 2021
Revised: 30 November 2021
Accepted: 30 November 2021
First Online: 10 February 2023
CONFLICT OF INTEREST
: The authors declare that they have no conflicts of interest.